Loading chat...
IN SB0445
Bill
Status
1/12/2015
Primary Sponsor
Brent Steele
Click for details
AI Summary
-
Classifies products containing ephedrine or pseudoephedrine as schedule IV controlled substances requiring prescription dispensing from July 1, 2015 through June 30, 2018, with exemptions for extraction or conversion resistant formulations approved by the Indiana board of pharmacy.
-
Permits the Indiana board of pharmacy to adopt emergency rules declaring products as extraction or conversion resistant if they pose significantly reduced risk of use in methamphetamine manufacturing.
-
Requires the state police superintendent to submit a report by July 1, 2017 to the legislative council, governor, chief justice, and interim study committee on corrections and criminal code regarding the impact of ephedrine and pseudoephedrine regulation.
-
Suspends most over-the-counter sale restrictions and tracking requirements for ephedrine and pseudoephedrine during the three-year period, though existing logs must be maintained for law enforcement access.
-
Establishes that violations constitute a Class C misdemeanor, escalating to Class A misdemeanor for repeat offenders.
Legislative Description
Ephedrine and pseudoephedrine. Provides that materials, compounds, mixtures, or preparations that contain ephedrine or pseudoephedrine are schedule IV controlled substances that may be dispensed only by prescription, except for a product that is determined by the Indiana board of pharmacy to be an extraction resistant or conversion resistant form of ephedrine or pseudoephedrine. Requires the superintendent of the state police to submit a report by July 1, 2017, regarding the impact of ephedrine and pseudoephedrine as a schedule IV controlled substance. Provides that this bill is effective from July 1, 2015, to June 30, 2018.
Last Action
Senator Head added as third author
1/15/2015